Synthesis and preliminary screening of benzothiazol-2-yl thiadiazole derivatives for anticonvulsant activity

Acta Pharmaceutica

Volumn 59, Issue 4, 2009, Pages 441-451

  Siddiqui, Nadeem ^a   Rana, Arpana ^a   Khan, Suroor ^a   Haque, S ^a   Arshad, M ^a   Ahmed, Sharique ^b   Ahsan, Waquar ^a  

^a HAMDARD UNIVERSITY   (India)

^b Misurata University   (Liechtenstein)

Author keywords

Anticonvulsant; Benzothiazole; Hepatotoxicity; Neurotoxicity; Thiadiazole

Indexed keywords

BENZOTHIAZOL 2 YL THIADIAZOLE DERIVATIVE; PHENYTOIN; THIADIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; MOUSE; NEUROTOXICITY; NONHUMAN; PHYSICAL CHEMISTRY; SEIZURE;

EID: 77949442787     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0031-x     Document Type: Article

References (13)

1. D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri and R. Zalutsky, How common are the common neurologic disorders?, Neurology 68 (2007) 326-337; DOI:10.1212/ 01.wnl.0000252807.38124.a3.
2. G. D. Cascino, Epilepsy: contemporary perspectives on evaluation and treatment, Mayo Clinic. Proc. 69 (1994) 1199-1211.
3. N. Siddiqui, S. N. Pandeya, S. A. Khan, J. P. Stables, A. Rana, M. Alam, M. F. Arshad and M. A. Bhat, Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain, Bioorg. Med. Chem. Lett. 17 (2007) 255-259; DOI:10.1016/j.bmcl.2006.09.053.
4. N. Siddiqui, A. Rana, S. A. Khan, M. A. Bhat and S. E. Haque, Synthesis of benzothiazole semicarbazones as novel anticonvulsants - The role of hydrophobic domain, Bioorg. Med. Chem. Lett. 17 (2007) 4178-4182; DOI:10.1016/j.bmcl.2007.05.048.
5. A. Rana, N. Siddiqui, S. A. Khan, S. E. Haque and M. A. Bhat, N--[(6-substituted-1,3-benzothiazole- 2-yl)amino]carbonothioyl--2/4-substituted benzamides: Synthesis and pharmacological evaluation, Eur. J. Med. Chem. 43 (2008) 1114-1122; DOI:10.1016/j.ejmech.2007.07.008.
6. H. N. Dogan, A. Duran, S. Rollas, G. Sener, M. K. Uysal and D. Gülen, Synthesis of new 2,5-disubstituted- 1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities, Bioorg. Med. Chem. 10 (2002) 2893-2898; DOI: 10.1016/S0968-0896(02)00143-8.
7. B. Masereel, S. Rolin, F. Abbate, A. Scozzafava and C. T. Supuran, Carbonic anhydrase inhibitors: Anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties, J. Med. Chem. 45 (2002) 312-320; DOI: 10.1021/jm0109199.
8. M. T. Silvina, C. M. Sung, E. B. Luis and L. E. Guillermina, Characterization of the anticonvulsant profile of valpromide derivatives, Bioorg. Med. Chem. 12 (2004) 3857-3869; DOI:10.1016/j. bmc.2004.05.003.
9. P. Yogeeswari, D. Sriram, V. Saraswat, R. J. Vaigunda, K. M. Mohan, S. Murugesan, R. Thirumurugan and J. P. Stables, Synthesis and anticonvulsant and neurotoxicity evaluation of N4- -phthalimido phenyl (thio) semicarbazides, Eur. J. Pharm. Sci. 20 (2003) 341-346; DOI: 10.1016/ j.ejps. 2003.08.002.
10. Archana, V. K. Srivatava and K. Ashok, Synthesis of newer thiadiazolyl and thiazolidinonyl quinazolin- 4(3H)-ones as potential anticonvulsant agents, Eur. J. Med. Chem. 37 (2002) 873-882; DOI:10.1016/S0223-5234(02)01389-2.
11. S. Reitman and S. A. Frankel, A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases, Am. J. Clin. Pathol. 28 (1957) 56-63.
12. E. J. King and A. R. Armstrong, A convenient method for determining serum and bile phosphatase activity, Can. Med. Assoc. J. 31 (1934) 376-381.
13. D. S. Sheriff, Practical Clinical Biochemistry Methods and Interpretations, 1st ed., Academa Publisher, Delhi 2004, pp. 38-39.